| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000028471 |
| Receipt No. | R000031013 |
| Scientific Title | Physiological and Psychological Changes of Primipara after First-time Interaction with Infant during Pregnancy |
| Date of disclosure of the study information | 2017/08/02 |
| Last modified on | 2019/05/30 (Ver. 3) |
| Basic information | ||
| Public title | Physiological and Psychological Changes of Primipara after First-time Interaction with Infant during Pregnancy | |
| Acronym | Physiological and Psychological Changes of Primipara after First-time Interaction with Infant during Pregnancy | |
| Scientific Title | Physiological and Psychological Changes of Primipara after First-time Interaction with Infant during Pregnancy | |
| Scientific Title:Acronym | Physiological and Psychological Changes of Primipara after First-time Interaction with Infant during Pregnancy | |
| Region |
|
|
| Condition | |||
| Condition | Low-risk primipara 38weeks of gestation. | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | YES | ||
| Objectives | |
| Narrative objectives1 | Comparing two groups to cralify the evidence of interact with infant.
Hypotheses: 1.The level of cortisol in intervention group is more decrease than controal group after intervention. 2.The score of STAI in intervention group is more decrease than control group after intervention. 3.The level of oxytoin in intervention group is more higer than controal group after intervention. 4.The score of TAIJI-KANJYO-SHAKUDO in intervention group is more change than controal group after intervention. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Change of salivary cortisol before and after interaction. |
| Key secondary outcomes | 1.Change of salivary oxytocin before and after interaction.
2.Change of score of STAI. 3.Change of score of TAIJI-KANJYO-SHAKUDO. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -but assessor(s) are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | YES |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | 30min of interacting with infant | |
| Interventions/Control_2 | 30min of seeing DVD of infant | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | 1.Low-risk primipara
2.Japanese 3.Plan to give birth with spontaneous delivary 4.More than 20years old 5.38weeks gestation |
|||
| Key exclusion criteria | 1.Complications of pregnancy
2.Current medical history or past history of endocrine disorders and psychiatric disorders 3.Oral or dental diseases 4.Professional child care-giver 5.Those performing nipple massage for induction of delivary |
|||
| Target sample size | 72 | |||
| Research contact person | |||||||
| Last name of lead principal investigator |
|
||||||
| Organization | St. Luke's International University, Postgraduate School | ||||||
| Division name | Nursing science, Women's Health and Midwifery | ||||||
| Zip code | |||||||
| Address | 10-1, Akashi-cho, Chuo-ku, Tokyo, 104-0044, Japan | ||||||
| TEL | 03-3543-6391 | ||||||
| shigeko-horiuchi@slcn.ac.jp | |||||||
| Public contact | |||||||
| 1st name of contact person |
|
||||||
| Organization | St. Luke's International University, Postgraduate School | ||||||
| Division name | Nursing science, Women's Health and Midwifery | ||||||
| Zip code | |||||||
| Address | 3-8-5, Tsukiji, Cuo-ku, Tokyo, 104-0045, Japan | ||||||
| TEL | 03-6226-6361 | ||||||
| Homepage URL | |||||||
| 15DN010@slcn.ac.jp | |||||||
| Sponsor | |
| Institute | St. Luke's International University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | KAKEN(16K15939) |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031013 |